Love this @USATODAY@USATODAYBooks The books is intended for entertainment and education, a little something something for everyone. Humor, thank goodness, isn't something you need approval for from health insurance co. @IASLC@zibbyowens
Very proud of @RyanKramer33 for an excellent presentation at #TTLC26 of a meta-analysis of neoadjuvant TKI trials. 👏👏👏
🔬MPR rate 25% across neoadj osi studies
⬇️ 80% of cT3 tumors have radiographic responses (enabling 😷🔪)
🩻 radiographic response not associated with MPR
One of the best sessions at #WTS25 : the vital role of thoracic surgeon scientists
From how to get involved in trials, to the importance of proper training and knowing where to start with the right funding opportunities
@DrAnnaMcGuire@MattSmeltzer@SteveYangMD Dr Sihag
Thank you @MattSmeltzer for kicking off Day 2 of #WTS2025 at our research methodology session, and to moderators Drs Ammara Watkins, Elizabeth Norton, and @SteveYangMD. Your Tree of Accuracy made epidemiology basics clear and practical for @WomenInThoracic attendees!
Thank you @MattSmeltzer for kicking off Day 2 of #WTS2025 at our research methodology session, and to moderators Drs Ammara Watkins, Elizabeth Norton, and @SteveYangMD. Your Tree of Accuracy made epidemiology basics clear and practical for @WomenInThoracic attendees!
@uofmemphis Doctoral student Jessica Rice presented results from the MSQSR cohort validating the overall survival difference in pN2a v pN2b in the v9 lung cancer staging system at #WCLC25@IASLC@ROsarogiagbon
Dr. G. Carmona De Souza GLOBOCAN analysis:
➡️ Lung cancer burden will nearly double by 2050
➡️ Female burden rising faster
➡️ Low and medium HDI countries face the largest increases
We need equitable targeted prevention, screening
#WCLC25@NarjustFlorezMD@pompili_cecilia
Now at #WCLC25 - Smoking is an important prognostic factor that adds to information provided by anatomical staging.
Further exploration of combining smoking status with TNM is planned in the 10th edition IASLC staging. @IASLC@Lawson_Eng
https://t.co/t0D3H1ZwD7
Key takeaways from an excellent discussion from @jessicalin of PL02.18Phase 3 Trial of Crizotinib vs Observation for Surgically Resected Early-Stage ALK+ NSCLC
@iaslc#WCLC25
Communications committee @IASLC pushing forward with insights, action, and a little Shakepeare! Excited to begin server with these humans. @DrJNaidoo@MattSmeltzer@TonyMok9
, Dr. Fiona Hegi-Johnson,
@AnaVManana
& Dr. Martin Edelman @lungoncdoc !
🫁 Thanks to @NarjustFlorezMD and Angela Morabito of @Florez_Lab for joining us at @IASLC#WCLC25 for a fantastic interview about their research on psychosocial needs in young patients with lung cancer, the LEAD study & #HearHer!
⭐ Stay tuned for the interview!
#lcsm